BACKGROUND: The possible relationship between periodontitis and juvenile idiopathic arthritis (JIA) is now mostly unknown but there are common characteristics in these two diseases. The purpose of this study is to evaluate etanercept (Enbrel®) effects on periodontal conditions of children affected by JIA. METHODS: For this study three group of patients were selected. The first one is represented by JIA subjects in pharmacologic therapy with etanercept (Enbrel®). The second one was composed by subjects in pharmacologic therapy with other drugs and the third one by healthy subjects. Twenty subjects for each group were selected. For each subject two periodontal scores were taken: Plaque Index and bleeding on probing. In order to check the reliability of the method a second registration has been performed in all the 3 groups after one month. A statistic Kruskal-Wallis test was performed. RESULTS: The average Plaque Index was 48% in the first group, 37% in the second group and 20% in the control group. The average Bleeding Index was 5% in the first group, 5% in the second group and 9% in the control group. CONCLUSIONS: Etanercept seems to reduce periodontal inflammation in children affected by JIA as the other therapy.

Periodontal conditions in juvenile idiopathic arthritis / C. Maspero, L. Giannini, G. Galbiati, C. Prevedello, G. Farronato. - In: MINERVA STOMATOLOGICA. - ISSN 0026-4970. - 66:2(2017), pp. 43-50.

Periodontal conditions in juvenile idiopathic arthritis

C. Maspero;L. Giannini;G. Galbiati;C. Prevedello;G. Farronato
2017

Abstract

BACKGROUND: The possible relationship between periodontitis and juvenile idiopathic arthritis (JIA) is now mostly unknown but there are common characteristics in these two diseases. The purpose of this study is to evaluate etanercept (Enbrel®) effects on periodontal conditions of children affected by JIA. METHODS: For this study three group of patients were selected. The first one is represented by JIA subjects in pharmacologic therapy with etanercept (Enbrel®). The second one was composed by subjects in pharmacologic therapy with other drugs and the third one by healthy subjects. Twenty subjects for each group were selected. For each subject two periodontal scores were taken: Plaque Index and bleeding on probing. In order to check the reliability of the method a second registration has been performed in all the 3 groups after one month. A statistic Kruskal-Wallis test was performed. RESULTS: The average Plaque Index was 48% in the first group, 37% in the second group and 20% in the control group. The average Bleeding Index was 5% in the first group, 5% in the second group and 9% in the control group. CONCLUSIONS: Etanercept seems to reduce periodontal inflammation in children affected by JIA as the other therapy.
Juvenile arthritis; Periodontitis; Etanercept; Oral hygiene
Settore MED/28 - Malattie Odontostomatologiche
2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
R18Y2017N02A0043.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 768.78 kB
Formato Adobe PDF
768.78 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/589676
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 4
social impact